Abramson Cancer Center at Penn Medicine: Head and Neck Neoplasms trials

The registry lists 11 Head and Neck Neoplasms studies with Abramson Cancer Center at Penn Medicine as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Photobiomodulation in Head and Neck Cancer-Related Chronic LymphedemaRecruitingNCT06837480Not applicable
• Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]RecruitingNCT06125743Not applicable
• Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckCompletedNCT01044433Phase 2Results posted
• ChatBot and Activity Monitoring in Patients Undergoing ChemoradiotherapyActive, not recruitingNCT05318027Phase 2
• Comparing Two Ways to Manage Head and Neck LymphedemaActive, not recruitingNCT05182229Not applicable
• Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer PatientsWithdrawnNCT04996641Not applicable
• HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck CancerCompletedNCT01984359Not applicable
• MLN8237 in Head and Neck CancerCompletedNCT01540682Phase 1
• MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck CancerCompletedNCT00984074
• Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck TumorsCompletedNCT00978081Phase 1
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT00003777Phase 2